Previous 10 | Next 10 |
home / stock / azncf / azncf news
Previously, I wrote how indiscriminate buying would be replaced with selectivity and that the market was approaching an important make-or-break moment following its rapid run-up since March. The S&P 500 remains below critical resistance, so the risk of weakness remains. However, our ...
Avrobio Collaborates with Magenta Therapeutics for Advancing Novel ADC Avrobio Inc. ( AVRO ) announced its latest collaboration with Magenta Therapeutics ( MGTA ) for advancing the latter's lead drug candidate MGTA-117. The tie-up will provide synergies for both the companies as Avrobio pr...
Starpharma VivaGel antiviral condom launched in Japan under Okamoto 003 brand Last month I wrote an article suggesting that Starpharma’s (OTCQX: OTCQX:SPHRY ) share price has been savaged by COVID-19 for no good reason. Now Starpharma is showing signs of fighting back against ...
Investment Thesis The stakes have never been higher for Moderna, Inc. ( MRNA ) as it battles a myriad of competitors in the race for a successful COVID-19 vaccine. The long and arduous process of vaccine development and testing has slim monetary gains and a low chance of success. Despite a...
Substantial fiscal and monetary intervention has fueled a dramatic run-up in shares; however, the market is approaching resistance, suggesting a make-or-break moment for the recent rally is approaching. Specifically, the S&P 500 is almost back to its 200-day moving average (DMA), raisi...
AstraZeneca PLC (AZN) Q1 2020 Earnings Conference Call April 29, 2020, 06:45 AM ET Company Participants Pascal Soriot - Chief Executive Officer Dave Fredrikson - Executive Vice President, Oncology Ruud Dobber - Executive Vice President, BioPharmaceutical Marc Dunoyer - Chief Fi...
The following slide deck was published by AstraZeneca PLC in conjunction with their 2020 Q1 earnings Read more ...
Quick Take ORIC Pharmaceuticals ( ORIC ) intends to raise $75 million in an IPO of its common stock, per an amended S-1/A registration statement . The company is advancing a pipeline of drug candidates for the treatment of prostate cancer and solid tumors. ORIC is led by extremely capab...
Quick Take Lantern Pharma ( LTRN ) has filed to raise $28.75 million in an IPO of its common stock, according to an S-1 registration statement . The firm is developing a pipeline of drug candidates for the treatment of prostate, lung and other cancers. LTRN seeks to use its proprietary ...
Sangamo Closes Gene Collaboration with Biogen Sangamo Therapeutics ( SGMO ) reported that it has finalized its sale of stock to Biogen ( BIIB ), leading to the formal initiation of its global licensing collaboration with latter. The collaboration pertains to gene regulation therapies in ...
News, Short Squeeze, Breakout and More Instantly...
Inaugural Asia Summit on Global Health successfully explores healthcare landscape HONG KONG, Nov 25, 2021 - (ACN Newswire) - Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural...
Inaugural Asia Summit on Global Health opens today HONG KONG, Nov 24, 2021 - (ACN Newswire) - Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural Asia Summit on Global Health (...
A new study with information regarding the “rare but devastating” blood clotting issue affiliated with the Oxford- AstraZeneca (OTCMKTS: AZNCF) Covid-19 vaccine has been released. Nevertheless, according to British scientists, there have been no new cases of blood cl...